6934
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways in the United States, Europe and Asia. The company's products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuate… Read more
6934 (6934) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.102x
Based on the latest financial reports, 6934 (6934) has a cash flow conversion efficiency ratio of -0.102x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-27.33 Million) by net assets (NT$266.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
6934 - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how 6934's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
6934 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 6934 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Teleste Oyj
HE:TLT1V
|
0.087x |
|
Annovis Bio Inc
NYSE:ANVS
|
-0.265x |
|
Equatorial Pará Distribuidora de Energia S.A
SA:EQPA3
|
0.156x |
|
Shanghai Huili Building Materials Co Ltd
SHG:900939
|
-0.016x |
|
Ta-Yuan Cogeneration Co Ltd
TWO:8931
|
0.116x |
|
ASICLAND
KQ:445090
|
-0.133x |
|
SCANA ASA NK 1
F:1MP
|
N/A |
|
Icares Medicus Inc
TWO:6612
|
-0.042x |
Annual Cash Flow Conversion Efficiency for 6934 (2020–2024)
The table below shows the annual cash flow conversion efficiency of 6934 from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$209.31 Million | NT$-32.54 Million | -0.155x | +61.42% |
| 2023-12-31 | NT$277.01 Million | NT$-111.61 Million | -0.403x | +9.30% |
| 2022-12-31 | NT$180.97 Million | NT$-80.40 Million | -0.444x | -486.18% |
| 2021-12-31 | NT$-172.32 Million | NT$-19.82 Million | 0.115x | -54.52% |
| 2020-12-31 | NT$-145.78 Million | NT$-36.88 Million | 0.253x | -- |